Ioannis Kanonidis

675 total citations
25 papers, 192 citations indexed

About

Ioannis Kanonidis is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ioannis Kanonidis has authored 25 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ioannis Kanonidis's work include Heart Failure Treatment and Management (10 papers), Cardiovascular Function and Risk Factors (5 papers) and Coronary Interventions and Diagnostics (4 papers). Ioannis Kanonidis is often cited by papers focused on Heart Failure Treatment and Management (10 papers), Cardiovascular Function and Risk Factors (5 papers) and Coronary Interventions and Diagnostics (4 papers). Ioannis Kanonidis collaborates with scholars based in Greece, United States and United Kingdom. Ioannis Kanonidis's co-authors include George Kassimis, Nikolaos P. E. Kadoglou, Antonios Ziakas, Adrian Banning, Haralambos Karvounis, Grigoris V. Karamasis, Giovanni Luigi De Maria, Μiltiadis Krokidis, Matthaios Didagelos and Georgia Valsami and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Medicine and European Heart Journal.

In The Last Decade

Ioannis Kanonidis

23 papers receiving 191 citations

Peers

Ioannis Kanonidis
Carly Adamson United Kingdom
Mehmed Kulić Bosnia and Herzegovina
Omar Issa United States
Ioannis Kanonidis
Citations per year, relative to Ioannis Kanonidis Ioannis Kanonidis (= 1×) peers Raquel Campuzano

Countries citing papers authored by Ioannis Kanonidis

Since Specialization
Citations

This map shows the geographic impact of Ioannis Kanonidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioannis Kanonidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioannis Kanonidis more than expected).

Fields of papers citing papers by Ioannis Kanonidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioannis Kanonidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioannis Kanonidis. The network helps show where Ioannis Kanonidis may publish in the future.

Co-authorship network of co-authors of Ioannis Kanonidis

This figure shows the co-authorship network connecting the top 25 collaborators of Ioannis Kanonidis. A scholar is included among the top collaborators of Ioannis Kanonidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioannis Kanonidis. Ioannis Kanonidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lam, Phillip H., Kevin Liu, Ali Ahmed, et al.. (2024). Digoxin Discontinuation in Patients With HFrEF on Beta-Blockers: Implication for Future 'Knock-Out Trials' in Heart Failure. The American Journal of Medicine. 138(3). 495–503.e1.
2.
Patel, Samir S., Phillip H. Lam, Amiya Ahmed, et al.. (2023). Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease. The American Journal of Medicine. 136(7). 677–686. 7 indexed citations
3.
Theodoropoulos, Konstantinos C., Sofia Vakalopoulou, George Stavropoulos, et al.. (2021). How to Manage a Patient with Haemophilia and ACS Requiring PCI: A Battle between Bleeding and Thrombosis. Medicina. 57(4). 352–352. 7 indexed citations
4.
Lam, Phillip H., Wilbert S. Aronow, Apostolos Tsimploulis, et al.. (2021). Initiation of Anti-Hypertensive Drugs and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction. The American Journal of Medicine. 135(6). 737–744. 2 indexed citations
5.
Kadoglou, Nikolaos P. E., Emmanouil Korakas, Christos D. Karkos, et al.. (2021). The prognostic role of RBP-4 and adiponectin in patients with peripheral arterial disease undergoing lower limb endovascular revascularization. Cardiovascular Diabetology. 20(1). 221–221. 8 indexed citations
6.
Kadoglou, Nikolaos P. E., John Parissis, Apostolos Karavidas, Ioannis Kanonidis, & Marialena Trivella. (2021). Assessment of acute heart failure prognosis: the promising role of prognostic models and biomarkers. Heart Failure Reviews. 27(2). 655–663. 12 indexed citations
7.
8.
Kadoglou, Nikolaos P. E., George Kassimis, Nikolaos Patsourakos, Ioannis Kanonidis, & Georgia Valsami. (2020). Omentin-1 and vaspin serum levels in patients with pre-clinical carotid atherosclerosis and the effect of statin therapy on them. Cytokine. 138. 155364–155364. 9 indexed citations
9.
Boulmpou, Aristi, George Kassimis, Dimitrios Mouselimis, et al.. (2020). Spontaneous Coronary Artery Dissection (SCAD): Case Series and Mini Review. Cardiovascular revascularization medicine. 21(11). 1450–1456. 11 indexed citations
10.
Ioannidis, Panagiotis, et al.. (2020). The evolution of mapping and ablation techniques in the treatment of atrial tachycardias occurring after atrial fibrillation ablation. Journal of Interventional Cardiac Electrophysiology. 60(3). 493–511. 2 indexed citations
11.
Vassilikos, Vassilios, Efstathios D. Pagourelias, Νikolaos Raikos, et al.. (2020). Impact of social containment measures on cardiovascular admissions and sudden cardiac death rates during Coronavirus Disease (COVID-19) outbreak in Greece. Hellenic Journal of Cardiology. 62(4). 318–319. 4 indexed citations
12.
Tsimploulis, Apostolos, Charles Faselis, Ioannis Kanonidis, et al.. (2019). ASSOCIATION OF ATRIAL FIBRILLATION AND OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION (HFPEF AND HFREF). Journal of the American College of Cardiology. 73(9). 797–797. 1 indexed citations
13.
Lam, Phillip H., Steven Singh, Milton Packer, et al.. (2019). Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction. The American Journal of Medicine. 132(11). 1311–1319. 16 indexed citations
15.
Sachpekidis, Vasileios, et al.. (2009). Carotid Sinus Hypersensitivity is Common in Patients Presenting with Hip Fracture and Unexplained Falls. Pacing and Clinical Electrophysiology. 32(9). 1184–1190. 8 indexed citations
16.
Karamouzis, Michalis V., et al.. (2002). Plasma Atrial Natriuretic Peptide in Essential Hypertension after Treatment with Irbesartan. Blood Pressure. 11(2). 91–94. 9 indexed citations
17.
Kanonidis, Ioannis, et al.. (2002). Plasma atrial natriuretic peptide levels in essential hypertension after treatment with verapamil. European Journal of Drug Metabolism and Pharmacokinetics. 27(1). 45–48. 6 indexed citations
18.
Kanonidis, Ioannis, et al.. (1998). Effect of the β1-Blocker/β2-Agonist Celiprolol on Atrial Natriuretic Peptide Plasma Levels in Hypertensive Patients. Cardiovascular Drugs and Therapy. 12(4). 345–346. 15 indexed citations
19.
Kanonidis, Ioannis, et al.. (1997). ANP concentrations during interchanging DDD-VVI pacing modes in patients with retrograde ventriculoatrial conduction.. PubMed. 52(1). 37–47. 6 indexed citations
20.
Kanonidis, Ioannis, et al.. (1996). The effect of trimetazidine on reperfusion arrhythmias in acute myocardial infarction. International Journal of Cardiology. 55(2). 137–142. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026